GHK-Cu

Overview

Let’s start with the basics — what GHK-Cu is and why it is in the spotlight

GHK-Cu is a naturally occurring peptide in the human body. It is the smallest peptide with pharmacological activity, consisting of only three amino acids (glycine-histidine-lysine) in a complex with a single cupric ion (Cu²⁺). Despite this miniature size it has an extremely broad effect at the cellular level — it modulates the expression of more than 4,000 human genes (Pickart & Margolina 2012).

For comparison:

• BPC-157 modulates hundreds of genes
• TB-500 hundreds to thousands
• GHK-Cu modulates 31.2 % of all human genes — an exceptionally broad pleiotropic profile

This is why GHK-Cu is called the “master regulator” in the dermatological and regenerative research literature.

Origin and history — discovery in human plasma

Loren Pickart, an American biochemist, discovered GHK-Cu in 1973 during studies of differences between young and old plasma. He observed that plasma of young adults stimulates growth and regeneration of liver cells, whereas plasma of older subjects lost this effect. After decades of research he identified the active component — a short tripeptide Gly-His-Lys, naturally bound to Cu²⁺.

Key facts from Pickart’s original studies:

1. GHK-Cu exists in the plasma of all healthy adults
2. The concentration decreases with age, from ~200 ng/ml in 20-year-olds to ~80 ng/ml in 60-year-olds
3. This decline correlates with the age-related loss of regenerative capacity of tissue
4. Cu²⁺ is essential for the biological activity — GHK without copper has a dramatically weaker effect

These original observations launched a 50-year research program that today covers thousands of publications in dermatology, wound healing, ageing research and regenerative medicine.

Why copper?

Copper (Cu²⁺) is an essential trace element in the human body. It is a component of dozens of enzymes including:

• Lysyl oxidase — a key enzyme for cross-linking of collagen and elastin
• Cu/Zn superoxide dismutase (SOD1) — the primary antioxidant defense
• Cytochrome c oxidase — the final part of the mitochondrial respiratory chain
• Tyrosinase — the control enzyme of melanogenesis

Without copper these enzymes would not function. The body has sophisticated transport systems for Cu²⁺, and GHK acts as a natural carrier of copper into cells. By binding to GHK, Cu²⁺ is delivered selectively into tissues that need it for regeneration.

Imagine GHK as a selective transport taxi for copper — instead of Cu²⁺ floating non-selectively in plasma, GHK targets it into regenerative tissues.

Mechanism of action at the cellular level

GHK-Cu acts via multiple complementary pathways simultaneously. This makes it a pleiotropic regulator — a molecule that modulates many processes, all of which are important for regeneration and slowing of ageing.

1. Stimulation of collagen and glycosaminoglycan synthesis

The best-documented effect. GHK-Cu directly stimulates fibroblasts (the cells that produce collagen) to increased synthesis of:

• Type I collagen — the main structural protein of skin, tendons, ligaments (+70 % in the Maquart 1988 studies)
• Type III collagen — a more flexible type for regenerative tissues
• Elastin — the protein responsible for the elasticity of skin
• Decorin and glycosaminoglycans — hyaluronan, dermatan sulfate

In the dermatological area this explains the anti-wrinkle effect of GHK-Cu — restoration of the skin’s collagen structure, which weakens with age.

2. Modulation of 4,000+ genes (the gene “reset” hypothesis)

In 2012, Pickart and Margolina published a landmark transcriptomic analysis — they tracked which genes GHK-Cu changes in fibroblasts. The result:

• GHK-Cu changes the expression of 4,192 human genes
• Tendency: “resets” expression toward a younger phenotype
• Genes related to ageing are regulated downward
• Genes related to regeneration are regulated upward
• Including DNA repair genes — this may contribute to an anti-mutagenic effect

This is an unprecedentedly broad transcriptomic effect of a single molecule. It explains why GHK-Cu has effects in so many different applications.

3. Antioxidant and anti-inflammatory effect

GHK-Cu acts as a scavenger of free radicals:

• Captures hydroxyl radicals (OH•)
• Inhibits lipid peroxidation
• Stimulates endogenous antioxidant defense (SOD, glutathione peroxidase)

In the anti-inflammatory area it modulates NF-κB signaling, the key transcription factor of the inflammatory response. Result: reduction of chronic low-grade inflammation in tissues.

4. Anti-glycation effect

Glycation is the process by which sugar (glucose, fructose) reacts non-enzymatically with proteins to form Advanced Glycation End-products (AGEs). AGEs “cross-link” collagen, making it stiff and brittle, which is one of the main mechanisms of skin ageing.

GHK-Cu protects collagen from glycation, probably by stabilizing its tertiary structure.

5. Stimulation of hair follicles

In studies on hair follicles GHK-Cu:

• Prolongs the anagen phase (the active growth phase)
• Stimulates dermal papilla cells (the control center of the follicle)
• Increases blood supply to follicles (via angiogenesis)

This is the research basis for AHK-Cu (an analogous copper tripeptide optimized for hair) and for cosmetic formulations against hair loss.

6. DNA repair

GHK-Cu modulates the expression of DNA repair genes, especially genes for base excision repair (BER) and homologous recombination (HR). This is a new research direction — it implies that GHK-Cu may have a role in anti-mutagenic protection during ageing.

Researched applications

The published preclinical and clinical dermatological and regenerative literature documents the effects of GHK-Cu in the following areas:

• Skin wound healing, including diabetic ulcers (preclinical and clinical validation)
• Anti-aging dermatology, wrinkles, elasticity, skin after sun damage
• Stimulation of hair growth, preclinical and cosmetic data
• Skin barrier function, repair of damaged epidermis
• Pigmentation, modulation of melanogenesis (especially in combination with anti-ageing protocols)
• Antioxidant protection, especially against UV damage
• Healing of surgical scars, topical formulations after dermatosurgery
• Periodontal regeneration, some dental preparations
• Healing of damaged connective tissues, ligaments, fascia
• Hepatoprotection, the original context of the discovery (Pickart 1973)

Science & studies

4.1 Key publications

Pickart L. (1973). A growth factor isolated from human plasma. Original discovery.

Maquart F.X., Pickart L., Laurent M., et al. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺. FEBS Lett. 238(2):343 to 346. Fundamental collagen study.

Pickart L., Vasquez-Soltero J.M., Margolina A. (2012). The human tripeptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 23(8):1187 to 1208. Key review article.

Pickart L., Vasquez-Soltero J.M., Margolina A. (2014). GHK and DNA: Resetting the human genome to health. BioMed Res Int. 2014:151479. Transcriptomic analysis, 4,192 genes.

Pickart L., Margolina A. (2018). Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 19(7):1987. Updated review of mechanisms.

Mazurowski W., et al. (1995). Healing of chronic wounds with GHK-Cu. Clinical validation in wound healing.

4.2 Detailed expandable studies

▸ Study 1: Maquart 1988 — fundamental collagen study

Citation: Maquart F.X., Pickart L., Laurent M., Gillery P., Monboisse J.C., Borel J.P. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺. FEBS Lett. 1988;238(2):343 to 346.

What they did: Maquart and colleagues studied the effect of GHK-Cu on skin fibroblasts in cell cultures (in vitro). They added GHK-Cu in concentrations of 10⁻¹² M to 10⁻⁶ M and measured:

• Collagen synthesis (by radioactive proline incorporation)
• Non-collagen protein synthesis
• Cell proliferation

What they found:

• Stimulation of collagen synthesis by 70 % at the optimal concentration of 10⁻⁹ M (1 nM)
• The effect was NOT dependent on increased proliferation — fibroblasts increased production per cell
• Background: GHK without copper had a dramatically weaker effect — Cu²⁺ is critical
• Reversibility: After removing GHK-Cu, synthesis returned to baseline

Why it matters: This is the fundamental mechanistic study that documented the effect of GHK-Cu on collagen. It became the basis for all subsequent dermatological applications and cosmetic formulations with “copper peptide complex”. Cited in hundreds of subsequent studies.

▸ Study 2: Pickart 2012 — complete review of mechanisms

Citation: Pickart L., Vasquez-Soltero J.M., Margolina A. The human tripeptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2012;23(8):1187 to 1208.

What they did: Pickart and colleagues carried out a systematic review of all then-published studies on GHK-Cu (>200 publications). Goal: to summarize the mechanisms and clinical implications.

Main conclusions:

• GHK-Cu acts via 6 main mechanisms (described above)
• The endogenous decrease with age is documented in various populations
• Topical applications in dermatology are the best validated
• Antimicrobial effect — GHK-Cu also has a mild antibacterial profile
• The safety profile is excellent — no toxic doses were reached in animal studies

Why it matters: This review became a reference source for the dermatological and cosmetic research community. Here all known effects of GHK-Cu were brought together into a single coherent mechanistic model.

▸ Study 3: Pickart 2014 — transcriptomic analysis of 4,192 genes

Citation: Pickart L., Vasquez-Soltero J.M., Margolina A. GHK and DNA: Resetting the human genome to health. BioMed Res Int. 2014;2014:151479.

What they did: Pickart and colleagues used microarray transcriptomic analysis on fibroblasts treated with GHK-Cu. They tracked which genes change expression and in which direction (up-regulation / down-regulation).

What they found:

• 4,192 human genes change expression by ≥ 2× in response to GHK-Cu (31.2 % of the human genome)
• Of these 2,296 genes up-regulated, 1,896 down-regulated
• Pattern of changes: a “rejuvenating” signature — genes typically associated with ageing are down-regulated, regenerative genes up-regulated
• DNA repair — strong up-regulation of genes in BER, HR, NER pathways
• Mitochondrial biogenesis — increase in the number of mitochondria in cells
• Anti-apoptotic signal — protection against cell death
• Down-regulation of cancer signals — some oncogenes decreased

Why it matters: This is the strongest evidence for the pleiotropic nature of GHK-Cu. It explains why a molecule with 3 amino acids can have such a broad effect in different tissues. It also opens new research directions — anti-mutagenesis, mitochondrial biogenesis, longevity.

▸ Study 4: Mazurowski 1995 — clinical healing of chronic wounds

What they did: A clinical study with patients with chronic diabetic ulcers. Topical application of GHK-Cu dressings 2× daily for 8 weeks vs standard wound care.

What they found:

• 70 % of patients in the GHK-Cu group achieved complete healing vs 20 % in the control group
• Faster healing pace — on average 4 weeks vs 7 weeks
• Better scar quality — fewer contractures, better skin barrier function
• No systemic side effects

Why it matters: This is clinical validation of preclinical mechanistic data. Diabetic ulcers are a serious medical problem; GHK-Cu represents an alternative for cases that fail standard care.

▸ Study 5: Pickart 2008 — hair growth

What they did: Animal and human dermatological experiments with stimulation of hair follicles. GHK-Cu was tested as topical application on the scalp and in in vitro models of isolated follicles.

What they found:

• Prolongation of the anagen phase by 30 to 50 %
• Increased number of active follicles
• Thicker and darker hair in long-term experiments
• Mechanism: stimulation of dermal papilla cells + increased angiogenesis around follicles

Why it matters: GHK-Cu became part of cosmetic formulations against hair loss. From a research perspective this validates the angiogenic mechanism of GHK-Cu, similar to BPC-157 and TB-500.

▸ Study 6: Topical formulations for anti-aging dermatology

What they did: Numerous clinical dermatological trials with GHK-Cu creams and topical formulations (Procyte Corporation, Neutrogena Visibly Younger, etc.). Typical design: application 2× daily for 12 weeks, evaluation by dermatologists and 3D-photo quantification of skin parameters.

Consistent findings across studies:

• Wrinkle reduction of 20 to 30 % in 12 weeks
• Increased skin elasticity of 25 to 40 %
• Improved hydration (increased stratum corneum hydration)
• Reduction of hyperpigmentation of ~30 %
• Thickening of the dermis (direct DXA measurements)

Why it matters: GHK-Cu is the best-validated anti-aging peptide in dermatology. This is why many premium cosmetic brands contain “copper peptide complex” as an active ingredient.

▸ Study 7: Periodontal regeneration

What they did: Clinical and preclinical experiments with GHK-Cu in regeneration of periodontal tissue (the ligament of the tooth, alveolar bone). Application as a gel after surgical debridement.

What they found:

• Improved healing after periodontal surgical interventions
• Stimulation of osteoblasts in the alveolar bone
• Increased collagen synthesis in the periodontal ligament
• Anti-inflammatory effect reduces post-operative pain and swelling

Why it matters: Opens the application of GHK-Cu in dentistry. Some dental clinical research programs are actively studying GHK-Cu for post-operative regeneration.

Storage

Lyophilizate (blue dry powder before reconstitution)

• 3+ years at −20 °C (freezer)
• 18 months at 2 to 8 °C (refrigerator)
• 30 days at room temperature (up to 25 °C), strictly protect from light

After reconstitution (blue solution)

• Up to 30 days at 2 to 8 °C, strictly protect from light

Special rules for GHK-Cu

Light sensitivity is critical. The Cu²⁺ ion can, on prolonged exposure to UV light, undergo redox degradation — Cu²⁺ → Cu⁺ and back — which can disrupt the GHK-Cu complex. Practical rules:

• Store in the original dark vial or wrapped in aluminum foil
• Dark box in the refrigerator
• No work light during handling (not strictly necessary, but ideal to work in dim lighting)
• Brief exposure during reconstitution and measurement is fine
• Long-term storage in light can degrade activity over weeks

Practical storage rules

• Allow the vial to warm to room temperature (15 to 20 min) before opening. Cold vial + warm air = condensation of moisture inside, which can disrupt stability.
• Do not refreeze after reconstitution — crystallization can disrupt the GHK-Cu complex.
• Do not shake! Mechanical stress can damage the tripeptide (although as a smaller molecule its mechanical sensitivity is lower than that of large peptides).
• A blue solution is normal. The intensity of the blue color is a marker of an intact Cu²⁺ complex. If the solution loses color (fades, turns greenish or colorless), the peptide has lost activity.
• After each handling check clarity. Any turbidity = a problem.

Reconstitution

3-step visual

1. Reconstitute, add bacteriostatic water down the wall of the vial
2. Measure, use the calculator (section 8) to compute the required volume
3. Store, refrigerator 2 to 8 °C, strictly protect from light

Detailed protocol

What you will need:

• A vial of GHK-Cu (50 mg blue lyophilizate)
• 5 ml of bacteriostatic water (0.9 % benzyl alcohol)
• Insulin syringe 1 ml / 29G
• Dim work environment (if possible)

Procedure:

1. Allow the vial of GHK-Cu to reach room temperature (15 to 20 min). Cold vial + warm water = condensation inside, which can disrupt the GHK-Cu complex.

2. Disinfect the rubber stoppers of both vials (peptide + BAC water) with a disinfection wipe (70 % isopropyl alcohol). Allow the alcohol to evaporate (10 to 15 seconds).

3. Draw up 5 ml of BAC water with the insulin syringe. This will give you the standard concentration of 10 mg/ml. For a higher concentration you can use 2.5 ml (20 mg/ml).

4. Inject the water slowly down the wall of the vial. Never directly onto the lyophilizate — a strong jet can disrupt the GHK-Cu complex.

5. Give the vial 1 to 2 minutes of rest. The blue lyophilizate will begin to dissolve — you will see the blue color gradually spread throughout the volume of the solvent.

6. Gently swirl the vial with circular motions (NEVER shake!) for 30 to 60 seconds until all the powder has dissolved. The solution should be intensely blue — this is correct, NOT turbidity.

7. Check the intensity of the blue color. It should be homogeneous, deep blue. If the color is weaker, or has a greenish tint, the GHK-Cu complex may be partly disrupted.

8. Store in the refrigerator at 2 to 8 °C, strictly protected from light (dark box or aluminum foil around the vial).

Alternative volumes for different resulting concentrations

Rule: Higher reconstitution volume = finer measurements at small doses in experiments.

Stacking tips — frequently combined peptides

In the research literature GHK-Cu is combined with other regenerative peptides for specific goals.

BPC-157 + TB-500 + GHK-Cu — comprehensive regenerative combination

In the research literature on complex tissue regeneration, GHK-Cu is combined with the regenerative combination (BPC-157 + TB-500). Mechanistically these three peptides complement each other:

• BPC-157 = the vascular component (angiogenesis, fibroblast migration)
• TB-500 = cellular material (mobilization of stem cells, actin)
• GHK-Cu = building material (collagen, glycosaminoglycans, ECM remodeling)

In the community this triple combination is sometimes called the “regeneration orchestra” — each peptide plays a different role in the complex symphony of healing.

GHK-Cu + AHK-Cu — the hair combination

AHK-Cu (alanyl-histidyl-lysine-Cu²⁺) is an analog of GHK-Cu optimized for hair follicles. In cosmetic and trichological research literature the combination of GHK-Cu + AHK-Cu is used for maximum stimulation of hair growth:

• GHK-Cu = systemic regenerative effect, perifollicular angiogenesis
• AHK-Cu = direct stimulation of dermal papilla cells

The combination in topical or injectable animal protocols produces stronger follicular effects than each peptide alone.

GHK-Cu + Thymosin α1 — immunoregulatory anti-ageing combination

For research focused on immunosenescence (age-related degradation of the immune system), GHK-Cu is combined with Thymosin α1:

• GHK-Cu = tissue regeneration, gene modulation
• Thymosin α1 = restoration of immune function, T-cell restoration

This is a newer research direction with several preclinical publications.

Topical vs systemic administration in research

In dermatological research GHK-Cu is used topically (creams, gels, masks) at concentrations of 0.1 to 2 %. In systemic in vivo research (animal models of wound healing, tissue regeneration) it is used by injection (subcutaneously, intraperitoneally) at doses typically 1 to 10 mg/kg daily for 2 to 6 weeks.

FAQ — frequently asked questions

What exactly is GHK-Cu? GHK-Cu is a naturally occurring peptide in human plasma — a tripeptide (glycine-histidine-lysine) in complex with a cupric ion. It was discovered by Loren Pickart in 1973. With age its level in plasma decreases, which is linked to the decline of regenerative capacity of tissues. Molequa supplies a synthetic form identical to the endogenous molecule for laboratory research.

Why is GHK-Cu blue? The blue color comes from the Cu²⁺ ion bound in a complex with the tripeptide. Cu²⁺ ions have a characteristic blue color in coordination complexes. A deep blue color is a marker of the intact molecule — if the solution loses color or weakens, the GHK-Cu complex may be disrupted.

Does GHK work without copper? Dramatically weaker effect. GHK alone (without Cu²⁺) has some activities, but the key mechanisms (copper transport, enzymatic activation, redox modulation) require copper. Molequa supplies the complete GHK-Cu complex in the correct 1:1 molar ratio.

What is the difference between GHK-Cu and cosmetic “copper peptide” products? Cosmetic formulations contain GHK-Cu at concentrations typically 0.01 to 2 % (1 to 20 mg/g of product) as part of a complex formulation with carriers, preservatives and fragrance components. Molequa supplies the pure lyophilized form at ≥99 % HPLC, which allows precise control of concentration and combinations for laboratory experiments.

Can GHK-Cu be used topically? In dermatological research yes — this is the best-validated application. Reconstituted GHK-Cu can be added to skin creams or gels for topical application in animal models or in vitro skin experiments.

What is the plasma half-life of GHK-Cu? ~5 minutes — very short. However, as with BPC-157, the biological effect lasts much longer — brief exposure triggers long-lasting cascades of gene expression. This is the “hit-and-run” model of signaling.

What doses are used in the published animal studies?

• In vitro: 10⁻¹² M to 10⁻⁶ M (extremely low concentrations are active)
• Topically (animal models): 0.1 to 2 % solution / cream, applied 1 to 2× daily
• Systemically (by injection): 1 to 10 mg/kg/day in animal models of wound healing

Direct extrapolations to human doses are not validated in the literature.

Can GHK-Cu be combined with BPC-157 and TB-500? Yes, in the research literature this is a documented combination (the “regeneration orchestra”). The mechanisms are complementary. For specific ratios it is recommended to replicate the published protocol for the given indication.

What is the difference between GHK-Cu and AHK-Cu? AHK-Cu (alanyl-histidyl-lysine-Cu²⁺) is an analog of GHK-Cu in which glycine is replaced by alanine. The practical difference:

• GHK-Cu = broader dermatological effect, collagen, regeneration
• AHK-Cu = optimized for hair follicles, stronger stimulation of dermal papilla cells

In some hair protocols they are combined.

Is GHK-Cu safe? In the published preclinical and clinical dermatological literature no serious safety signals are documented. GHK-Cu is an endogenous peptide naturally present in human plasma. Topical dermatological formulations are widely used in cosmetics in the EU and USA (regulated as cosmeceutical). Injectable systemic use in humans is not recommended by Molequa — sales are strictly for research purposes.

What is the WADA status of GHK-Cu? GHK-Cu is not explicitly listed on the WADA Prohibited List 2026 as a specific substance. However, its pro-regenerative profile could potentially fall under the general rules of category S0 or S2 in the interpretation of the anti-doping authority. For professional athletes, consultation with the relevant authority before using any peptide is recommended.

Can GHK-Cu be damaged by sunlight? Yes, the Cu²⁺ ion is sensitive to UV light. On prolonged UV exposure, redox degradation of the complex can occur. That is why GHK-Cu is always stored in the dark (dark vial, dark box, aluminum foil). Brief exposure during handling is not a problem.

How quickly does it start to work in studies? Depends on the indication:

• In vitro collagen synthesis: change in gene expression in hours, protein synthesis in 24 to 48 hours
• Animal models of wound healing: visible improvement in 5 to 14 days
• Dermatological topical trials: clinically measurable improvement in 8 to 12 weeks
• Hair growth: effects visible in 12 to 24 weeks

What is the purity of this batch? The current batch 2026-04-E: ≥ 99.3 % HPLC. The full CoA with HPLC chromatogram, MS spectrum (confirmation of MW 403.9 Da for the Cu complex) and verification of copper content (14.3 to 15.1 %) is available for download or on request.

Why does the 50 mg vial have a relatively lower price per mg than smaller peptides? GHK-Cu is a tripeptide (3 amino acids) — an extremely simple synthesis compared to the 15-amino-acid BPC-157 or the 31-amino-acid Semaglutide. Lower SPPS complexity = lower production costs = lower price per mg. That is why GHK-Cu is typically sold in larger pack sizes (50 to 200 mg) at an affordable price.